CD8A and glioma: We demonstrated that the proliferation of CD4+ T within PBMCs treated with GSC-derived exosomes was inhibited, whereas there were no significant effects on CD8+ T cells, supporting the results obtained in [34], in which glioma-derived exosomes failed to alter the activation and INF-γ production by CD8+ T cells.